NFKB1 and inflammatory bowel disease: In UC mice models exhibiting a type of IBD, FMT alleviated UC symptoms by improving DAI scores, restoring gut microbiota function, increasing SCFA levels, and inhibiting NF-κB signaling, thereby reducing inflammation [362].